Antisense compounds, compositions and methods are provided for modulating
the expression of human PARP. The compositions comprise antisense
compounds, particularly antisense oligonucleotides, targeted to nucleic
acids encoding human PARP. Methods of using these compounds for modulation
of human PARP expression and for treatment of diseases associated with
expression of human PARP are provided.